STML

Stemline Therapeutics, Inc.
STML

Delisted

STML was delisted on the 9th of June, 2020.

96 hedge funds and large institutions have $555M invested in Stemline Therapeutics, Inc. in 2019 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 37 increasing their positions, 28 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
96
Holders Change
-2
Holders Change %
-2.04%
% of All Funds
2.09%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.07%
New
17
Increased
37
Reduced
28
Closed
17
Calls
$784K
Puts
$2.28M
Net Calls
-$1.5M
Net Calls Change
+$911K
Name Holding Trade Value Shares
Change
Shares
Change %
LSC
101
Lyon Street Capital
California
-$545K -42,396 Closed
AG
102
Algert Global
California
-$478K -37,171 Closed
TI
103
Trexquant Investment
Connecticut
-$395K -30,738 Closed
Jacobs Levy Equity Management
104
Jacobs Levy Equity Management
New Jersey
-$384K -29,864 Closed
Squarepoint
105
Squarepoint
New York
-$225K -17,545 Closed
Invesco
106
Invesco
Georgia
-$196K -15,263 Closed
HP
107
Hikari Power
Japan
-$194K -15,136 Closed
AI
108
Atria Investments
North Carolina
-$139K -10,827 Closed
CSS
109
Cubist Systematic Strategies
Connecticut
-$87K -6,788 Closed
WAM
110
Wealthspire Advisors (Maryland)
Maryland
-$19K -1,470 Closed
KPW
111
Kore Private Wealth
New York
-$13K -1,000 Closed
PHK
112
Point72 Hong Kong
Hong Kong
-$1K -44 Closed